{"id":180114,"date":"2026-08-14T08:44:10","date_gmt":"2026-08-14T08:44:10","guid":{"rendered":"https:\/\/pabau.com\/?p=180114"},"modified":"2026-08-14T11:17:26","modified_gmt":"2026-08-14T11:17:26","slug":"hcpcs-code-j0800","status":"publish","type":"post","link":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/","title":{"rendered":"HCPCS code J0800: Corticotropin injection billing guide"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"HCPCS code J0800: Corticotropin injection billing guide\",\"description\":\"HCPCS Code J0800 (injection, corticotropin, up to 40 units) was deleted on September 30, 2023 and replaced by two product-specific codes: J0801 for H.P. Acthar Gel and J0802 for Purified Cortrophin Gel. Learn the crosswalk, Medicare Part B coverage, buy-and-bill process, ICD-10 diagnosis codes, prior authorization, units billing, and applicable modifiers.\",\"url\":\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0800\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-08-07\",\"dateModified\":\"2026-08-14\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>HCPCS code J0800 (injection, corticotropin, up to 40 units) was deleted on September 30, 2023 and is no longer billable<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>CMS replaced it with two product-specific codes on October 1, 2023: J0801 for H.P. Acthar Gel and J0802 for Purified Cortrophin Gel<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>The \u00ab\u00a0(ani)\u00a0\u00bb in J0802 stands for ANI Pharmaceuticals, the maker of Cortrophin Gel, not for an animal source<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Both products are porcine-derived ACTH gels, so the code follows the brand in the vial, not the drug&rsquo;s origin<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Practice management software like Pabau tracks J-code crosswalks, NDC data, and prior auth status so buy-and-bill claims clear on the first submission<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">HCPCS code J0800 carried the official description \u00ab\u00a0injection, corticotropin, up to 40 units.\u00a0\u00bb It was the Level II J-code used to bill corticotropin (adrenocorticotropic hormone, or ACTH) given by injection in a physician office or outpatient setting. CMS deleted it effective September 30, 2023.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The replacement is not a single code. On October 1, 2023, CMS activated two product-specific codes: J0801 for H.P. Acthar Gel and J0802 for Purified Cortrophin Gel. Which one belongs on the claim depends on which product the practice bought and administered.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">J0800<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">J0801<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">J0802<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Official description<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, corticotropin, up to 40 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, corticotropin (acthar gel), up to 40 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, corticotropin (ani), up to 40 units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code status<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Deleted 9\/30\/2023<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Active since 10\/1\/2023<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Active since 10\/1\/2023<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Product billed<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Any repository corticotropin injection, before the deletion date<\/td>\n<td style=\"padding:12px 16px;color:#374151\">H.P. Acthar Gel only<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Purified Cortrophin Gel only<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Manufacturer<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Not product-specific<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Mallinckrodt Pharmaceuticals<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ANI Pharmaceuticals<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Drug source<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Porcine-derived ACTH gel<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Porcine-derived ACTH gel<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Porcine-derived ACTH gel<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billing unit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit = up to 40 USP units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit = up to 40 USP units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit = up to 40 USP units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billing model<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Buy-and-bill<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Buy-and-bill<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Buy-and-bill<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Use on claims today<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No, the code will be denied<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes, for Acthar Gel claims<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes, for Cortrophin Gel claims<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Because J0800 is deleted, submitting it on a new claim draws a rejection from Medicare and from commercial payers. The <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/healthcare-common-procedure-system\" target=\"_blank\" rel=\"nofollow noopener\">Centers for Medicare and Medicaid Services (CMS) HCPCS system<\/a> assigns and retires codes on a quarterly and annual cycle. Confirm the active code set in the current CMS HCPCS release file before submitting any corticotropin claim.<\/p>\n\n\n\n<h2 id=\"h-code-status-j0800-split-into-two-replacement-codes\" class=\"wp-block-heading\">Code status: J0800 split into two replacement codes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CMS retired J0800 on September 30, 2023 and activated J0801 and J0802 the next day. The split was made by product, not by drug source. Each successor code is tied to one brand of repository corticotropin injection, and payer policies enforce that tie.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The crosswalk from J0800 is therefore conditional. Claims that would once have gone out under J0800 for Acthar Gel now go out under J0801. Claims for Cortrophin Gel now go out under J0802. Everything else about the claim carries over: the unit convention, the buy-and-bill model, and the NDC requirement.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Attribute<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">J0800 (deleted)<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">J0801 (active)<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">J0802 (active)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Last date billable<\/td>\n<td style=\"padding:12px 16px;color:#374151\">September 30, 2023<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Still active<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Still active<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">First date billable<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Retired, no new dates of service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2023<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2023<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Bill it for<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Nothing on current dates of service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">H.P. Acthar Gel, from Mallinckrodt<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Purified Cortrophin Gel, from ANI<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Do not bill it for<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Any current corticotropin claim<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cortrophin Gel<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Acthar Gel<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Unit convention<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit = up to 40 USP units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit = up to 40 USP units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit = up to 40 USP units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Medicare payment basis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No longer priced<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASP+6%, its own quarterly payment limit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASP+6%, its own quarterly payment limit<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Outcome if submitted today<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Denied as an invalid code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Payable when the product and diagnosis match<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Payable when the product and diagnosis match<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Historical claims paid under J0800 before the deletion date need no corrective action. Practices reprocessing a denied legacy claim should follow the payer&rsquo;s adjustment guidelines for the original date of service.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For every current date of service, the code has to be J0801 or J0802. Tracking code crosswalks inside an updated <a href=\"https:\/\/pabau.com\/features\/claims-management-software\/\">claims management workflow<\/a> stops this type of denial from repeating across accounts.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0800\/automate-claims-through-healthcode.webp\" alt=\"Automate claims and billing with Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&rsquo;s claims management sends each corticotropin line out with the code, the NDC, and the unit count already matched.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-what-ani-in-j0802-means\" class=\"wp-block-heading\">What \u00ab\u00a0(ani)\u00a0\u00bb in J0802 means<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The \u00ab\u00a0(ani)\u00a0\u00bb in J0802&rsquo;s descriptor is short for ANI Pharmaceuticals, the company that makes Purified Cortrophin Gel. It identifies a manufacturer, not a drug source. Reading it as \u00ab\u00a0animal\u00a0\u00bb is what sends most misrouted corticotropin claims to the wrong code.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Animal sourcing cannot separate the two codes, because it does not separate the two products. Acthar Gel and Cortrophin Gel are both porcine-derived ACTH gels. The brand in the vial is the only thing that puts a claim on J0801 rather than J0802.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payer billing guidance says so directly. Commercial and Medicare Advantage policies state that J0801 applies to Acthar Gel only, and that J0802 applies to Cortrophin Gel only. A claim that pairs an Acthar Gel NDC with J0802 fails that product edit even when the diagnosis, units, and authorization are all correct.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Check the code against the NDC on the vial before the claim goes out. A Mallinckrodt Acthar Gel NDC belongs on a J0801 line, and an ANI Cortrophin Gel NDC belongs on a J0802 line. If your charge master still carries one generic corticotropin entry left over from J0800, split it into two entries now.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-what-drug-does-j0800-represent\" class=\"wp-block-heading\">What drug does J0800 represent?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Corticotropin, also called adrenocorticotropic hormone (ACTH), is a pituitary hormone that stimulates the adrenal cortex to produce cortisol and other corticosteroids. In practice it is given as repository corticotropin injection, a gel formulation that releases the hormone slowly after a subcutaneous or intramuscular dose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Two branded products carry that formulation in the United States. H.P. Acthar Gel comes from Mallinckrodt Pharmaceuticals and bills under J0801. Purified Cortrophin Gel comes from ANI Pharmaceuticals and bills under J0802. Both are prescription-only, and practices usually acquire both for buy-and-bill administration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Their FDA-approved indications overlap heavily. Both labels cover:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Acute exacerbations of multiple sclerosis<\/li>\n\n\n\n<li>Nephrotic syndrome without uremia, to induce diuresis or remission of proteinuria<\/li>\n\n\n\n<li>Rheumatic disorders: psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis<\/li>\n\n\n\n<li>Collagen diseases: systemic lupus erythematosus, systemic dermatomyositis (polymyositis)<\/li>\n\n\n\n<li>Dermatologic conditions: severe erythema multiforme, Stevens-Johnson syndrome<\/li>\n\n\n\n<li>Ophthalmic conditions: severe acute and chronic allergic and inflammatory processes involving the eye<\/li>\n\n\n\n<li>Respiratory conditions: symptomatic sarcoidosis<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Two indications sit on only one label, and those two decide the code by themselves:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Infantile spasms (West syndrome)<\/strong> in infants and children under two years is an Acthar Gel indication, so it supports J0801<\/li>\n\n\n\n<li><strong>Acute gouty arthritis flares<\/strong> is a Cortrophin Gel indication, so it supports J0802<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Corticotropin claims come from a narrow set of settings. Neurology and rheumatology offices bill most of them. <a href=\"https:\/\/pabau.com\/industry\/dermatology-emr-software\/\">Dermatology practices<\/a> use it for severe erythema multiforme and Stevens-Johnson syndrome. <a href=\"https:\/\/pabau.com\/industry\/iv-therapy-emr-software\/\">IV therapy practices<\/a> handle the doses given on site.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Coverage under Medicare and commercial plans usually narrows to a subset of the label. Local Coverage Determinations (LCDs) and payer medical policies set that narrower list. Verify the supported diagnoses against the current LCD from the relevant Medicare Administrative Contractor before submitting a claim.<\/p>\n\n\n\n<h2 id=\"h-medicare-part-b-coverage-and-reimbursement\" class=\"wp-block-heading\">Medicare Part B coverage and reimbursement<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare Part B covers physician-administered drugs, including repository corticotropin injection, when medical necessity is established and the drug is given in a covered setting. Coverage applies to J0801 and J0802 when a qualifying diagnosis is documented and the claim meets every submission requirement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Reimbursement follows the Average Sales Price (ASP) methodology, at ASP+6% of the drug&rsquo;s acquisition cost per unit billed. J0801 and J0802 are priced separately, so each carries its own payment limit in the quarterly ASP file. CMS republishes those limits every quarter, so the allowable amount moves across the year.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Published dollar figures for these codes go stale within a quarter. Verify the current rate in the <a href=\"https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/overview\" target=\"_blank\" rel=\"nofollow noopener\">CMS Physician Fee Schedule lookup tool<\/a> and the current ASP pricing file before submitting claims or projecting revenue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Key Medicare Part B coverage criteria for corticotropin injection:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The drug must be physician-administered, not self-administered by the patient<\/li>\n\n\n\n<li>The claim must carry a supporting ICD-10 diagnosis code that establishes medical necessity<\/li>\n\n\n\n<li>The NDC (National Drug Code) must be reported per CMS Part B drug billing requirements, and it must match the code billed<\/li>\n\n\n\n<li>Place of service must be a covered outpatient or physician office setting<\/li>\n\n\n\n<li>Prior authorization is required by many Medicare Advantage plans and commercial payers (see the prior authorization section below)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Traditional Medicare fee-for-service does not require prior authorization for corticotropin in every case, but Medicare Advantage plans frequently do. Billing staff should confirm authorization requirements with the specific plan before the drug is acquired, not after it is administered. Effective <a href=\"https:\/\/pabau.com\/blog\/hipaa-compliance-for-medical-offices\/\">medical office compliance workflows<\/a> treat payer-specific prior auth checks as a mandatory pre-administration step.<\/p>\n\n\n\n<h2 id=\"h-supported-icd-10-diagnosis-codes-for-corticotropin-claims\" class=\"wp-block-heading\">Supported ICD-10 diagnosis codes for corticotropin claims<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Every corticotropin injection claim needs a supporting ICD-10-CM diagnosis code that establishes medical necessity. Submitting J0801 or J0802 without a covered diagnosis results in denial.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The codes below map to FDA-approved and Medicare-covered indications, but coverage still depends on each payer&rsquo;s LCD and medical policy. Verify with the <a href=\"https:\/\/www.aapc.com\/codes\/hcpcs-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC HCPCS code lookup<\/a> and the applicable LCD before billing.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Clinical context and code it supports<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">G40.822<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Epileptic spasms, not intractable, without status epilepticus<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Infantile spasms (West syndrome). On the Acthar Gel label only, so it supports J0801<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">G40.821<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Epileptic spasms, not intractable, with status epilepticus<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Infantile spasms with status. Acthar Gel indication, so it supports J0801<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">M10.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Gout, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Acute gouty arthritis flare. On the Cortrophin Gel label only, so it supports J0802<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">G35<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Multiple sclerosis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">MS exacerbations. On both labels, so it supports J0801 or J0802<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">N04.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Nephrotic syndrome with unspecified morphologic changes<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Idiopathic nephrotic syndrome, to induce diuresis or remission of proteinuria. Both labels<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">M05.79<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Rheumatoid arthritis with rheumatoid factor of multiple sites<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Acute rheumatoid arthritis episodes, short-term adjunctive therapy. Both labels<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">M32.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Systemic lupus erythematosus, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Collagen disease indication, during an acute exacerbation. Both labels<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D86.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Sarcoidosis, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Symptomatic sarcoidosis, the respiratory indication on both labels<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Documentation has to support the diagnosis code you select. Infantile spasms claims typically need EEG findings and the clinical diagnosis note. MS exacerbation claims should have MRI and neurological assessment records in the chart.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payer auditors scrutinize corticotropin claims because the drug cost is high. Comprehensive <a href=\"https:\/\/pabau.com\/features\/medical-records-management\/\">clinical record documentation<\/a> is the front-line defense against retrospective denials.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0800\/comprehensive-patient-records.webp\" alt=\"Comprehensive patient records\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&rsquo;s client records hold the EEG report, the diagnosis note, and the administration record where an auditor can follow them.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-buy-and-bill-process-for-corticotropin-injection\" class=\"wp-block-heading\">Buy-and-bill process for corticotropin injection<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Acthar Gel and Cortrophin Gel are both usually billed under the buy-and-bill model. The practice acquires the drug, administers it, and then bills the payer for the drug and the administration. That differs from a specialty pharmacy model, where the payer reimburses the pharmacy directly.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Office of Inspector General (OIG) treats high-cost buy-and-bill drugs as a compliance risk area. Billing staff should handle every step as a potential audit touchpoint. The steps below reflect standard practice, so confirm current CMS claim submission requirements before you build them into a workflow.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Verify coverage and obtain prior authorization:<\/strong> Contact the payer before acquiring the drug. PA requirements are common across Medicare Advantage and commercial plans for both products. Buying the vial before authorization is confirmed creates financial exposure if the claim is denied.<\/li>\n\n\n\n<li><strong>Acquire the drug through an authorized channel:<\/strong> Order through a contracted specialty distributor and keep the acquisition cost documentation for audit purposes. Record the lot number and the NDC for each vial received, because the NDC determines which code the claim uses.<\/li>\n\n\n\n<li><strong>Administer and document:<\/strong> Record the date of administration, the dose in USP units, the route, the site, and the administering provider. The clinical note has to link directly to the ICD-10 diagnosis code on the claim.<\/li>\n\n\n\n<li><strong>Report the NDC on the claim:<\/strong> CMS requires NDC reporting on all Part B physician-administered drug claims. Report the 11-digit NDC, the unit of measure qualifier, and the quantity administered on the claim line.<\/li>\n\n\n\n<li><strong>Submit the claim with the product-specific code:<\/strong> Use J0801 for Acthar Gel and J0802 for Cortrophin Gel. Never use the deleted J0800. Include the ICD-10 diagnosis code, place of service, modifiers, and NDC information.<\/li>\n\n\n\n<li><strong>Reconcile payment against the ASP allowable:<\/strong> Compare the Medicare Remittance Advice payment to the current ASP+6% limit for the code you billed. A discrepancy may point to a billing error or a contractual adjustment worth following up.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">For practices managing several buy-and-bill drugs, this process gains a lot from integrated <a href=\"https:\/\/pabau.com\/procedure-codes\/ivf-cpt-codes\/\">procedure code tracking<\/a> and workflow automation. Other office-administered injectables such as <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1450\/\">J1450<\/a> move through the same six steps. Manual NDC logging is slow and error-prone at scale.<\/p>\n\n\n\n<h2 id=\"h-units-billing-and-dosage-reporting\" class=\"wp-block-heading\">Units billing and dosage reporting<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The \u00ab\u00a0up to 40 units\u00a0\u00bb language in the descriptor defines the billing unit rather than the dose. One billing unit represents up to 40 USP units of corticotropin. An 80-unit dose is therefore reported as 2 units. This convention is identical for J0801 and J0802, and it carried over unchanged from J0800.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Other J-codes phrase their unit the same way. <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1460\/\">J1460<\/a> is defined in cc rather than USP units, so read the descriptor before converting any dose.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Billing element<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Requirement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS unit definition<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 billing unit = up to 40 USP units of corticotropin, for both J0801 and J0802<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Dose conversion<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Divide the administered dose by 40 and round up: 40 units = 1 unit, 80 units = 2 units, 120 units = 3 units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code selection<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0801 for Acthar Gel, J0802 for Cortrophin Gel. The code must match the NDC on the same claim line<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">NDC format<\/td>\n<td style=\"padding:12px 16px;color:#374151\">11-digit NDC in 5-4-2 format with no dashes, preceded by the qualifier \u00ab\u00a0N4\u00a0\u00bb<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">NDC quantity<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Report the quantity administered in the vial&rsquo;s own unit of measure, which is ML for these gels, not the HCPCS unit count<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Wastage reporting<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Modifiers JW and JZ apply to single-dose containers only. Check the vial, since the 5 mL gels are multiple-dose<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Payer quantity limits<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Many plans cap units per date of service, so check the medical policy before billing a large dose<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Incorrect units reporting on a J-code buy-and-bill claim is a leading cause of line-level denials and post-payment audits. Billing 80 where the payer expects 2 can look like a 40-fold overbill. Accurate per-administration records in the <a href=\"https:\/\/pabau.com\/features\/prescription-management-software\/\">prescription management<\/a> workflow keep what was administered and what was billed in step.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0800\/prescribe-controlled-drugs-safely-and-stay-compliant.webp\" alt=\"Prescribe controlled drugs safely and stay compliant\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&rsquo;s prescription management captures the dose in USP units at administration, so the billed unit count matches the chart.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-prior-authorization-requirements-for-corticotropin\" class=\"wp-block-heading\">Prior authorization requirements for corticotropin<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Repository corticotropin injection is among the most expensive drugs billed under the buy-and-bill model. Prior authorization requirements are strict and close to universal as a result. A practice that administers either product without confirmed PA faces a full denial and keeps the acquisition cost.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Authorizations are usually issued for a named product, so an approval for one gel does not automatically cover the other. If the practice switches between Acthar Gel and Cortrophin Gel, confirm the PA still matches the product before the next dose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PA requirements vary substantially by payer type:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Traditional Medicare (fee-for-service):<\/strong> PA is not universally required for corticotropin. Individual Medicare Administrative Contractors may still impose coverage criteria and documentation requirements through Local Coverage Determinations. Verify with the relevant MAC for your region.<\/li>\n\n\n\n<li><strong>Medicare Advantage:<\/strong> Most MA plans require PA for both products. Criteria often include documented failure of alternative therapies, specialist referral notes, and a clinical rationale specific to the plan&rsquo;s coverage policy.<\/li>\n\n\n\n<li><strong>Medicaid:<\/strong> PA is required in most states. Medicaid criteria and covered diagnoses vary by state program.<\/li>\n\n\n\n<li><strong>Commercial insurance:<\/strong> Virtually all commercial plans require PA. Step therapy is common, so the file often has to show that lower-cost alternatives were tried and failed.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Standard PA documentation includes the prescriber&rsquo;s clinical notes supporting the diagnosis and, where applicable, EEG or MRI results. Payers also want evidence of prior treatments tried and failed, plus the proposed dose, frequency, and duration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tracking PA numbers, expiration dates, and reauthorization timelines is a heavy load for practices billing high-cost J-codes. The same load applies to other expensive biologics, including <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1562\/\">J1562<\/a>. A <a href=\"https:\/\/pabau.com\/procedure-codes\/coaching-cpt-codes\/\">procedure code billing workflow<\/a> works best when PA records link to the appointment and the claim.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Flag PA expiration dates in your billing system at least 30 days before the authorization period ends. Corticotropin approvals often run for three to six months. Administering a dose after the PA expires, even by one day, results in a full denial with no right of appeal on authorization grounds.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-modifiers-that-apply-to-corticotropin-claims\" class=\"wp-block-heading\">Modifiers that apply to corticotropin claims<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Several HCPCS modifiers apply to corticotropin injection claims. Picking the right one lowers denial risk and satisfies CMS documentation requirements for Part B drug billing. The modifiers below are the ones most relevant to J0801 and J0802, and historically to J0800.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Modifier<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">When to use<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JW<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug amount discarded and not administered to any patient<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When drug from a single-dose container is wasted; report the wasted units on a separate line<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JZ<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Zero drug wastage, nothing discarded<\/td>\n<td style=\"padding:12px 16px;color:#374151\">On single-dose container claims where no drug is wasted; CMS requires it when JW does not apply<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">KD<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug or biological infused through DME<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When the drug is administered through durable medical equipment; uncommon for corticotropin<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">GY<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Item or service excluded from Medicare<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When billing a non-covered indication to generate a denial for a secondary payer or the patient<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">GA<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Waiver of liability statement on file<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When you expect a Medicare denial and an Advance Beneficiary Notice (ABN) is on file<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">JW and JZ are tied to the container, not to the code. Both corticotropin gels ship in multiple-dose 5 mL vials, and a multiple-dose vial is outside the JW and JZ policy. Check the vial size and type on the packaging before appending either modifier.<\/p>\n\n\n\n<h3 id=\"h-place-of-service-codes\" class=\"wp-block-heading\">Place of service codes<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Place of service (POS) affects reimbursement under Medicare. Corticotropin injection is most often given in a physician office (POS 11) or a hospital outpatient department (POS 22). The distinction matters because Medicare applies different payment rules:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>POS 11 (physician office):<\/strong> Full ASP+6% reimbursement applies. This is the standard buy-and-bill setting for both gels.<\/li>\n\n\n\n<li><strong>POS 22 (outpatient hospital):<\/strong> Payment falls under the Outpatient Prospective Payment System (OPPS), which may bundle the drug into the administration APC rate. Verify expected reimbursement before administering in that setting.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">An incorrect POS code is a common claim editing error on buy-and-bill drugs, and it can trigger a reduced payment or a medical review request. Confirm the actual setting of service on every encounter before submission. When J-code billing runs across several locations, reviewing your broader <a href=\"https:\/\/pabau.com\/procedure-codes\/adhd-screening-cpt-code\/\">procedure code billing accuracy<\/a> surfaces systemic errors before they accumulate.<\/p>\n\n\n\n<h2 id=\"h-how-practice-management-software-simplifies-corticotropin-j-code-billing\" class=\"wp-block-heading\">How practice management software simplifies corticotropin J-code billing<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The billing workflow for high-cost J-code drugs involves more interdependent steps than most procedure-based claims. One break in the chain produces a full denial on a drug that can cost thousands of dollars per vial.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">An expired authorization, a mismatched NDC, or a retired code left in the charge master will each do it. Practice management software like Pabau closes several of those failure points. Pabau&rsquo;s claims management supports the billing cycle end to end, from the clinical note through claim submission and payment reconciliation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The J0801 and J0802 workflow benefits most from software that handles these requirements:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Code crosswalk tracking:<\/strong> When CMS retires a code and splits it in two, every claim template, superbill, and charge master entry needs updating. A centralized code library makes that transition systematic instead of manual.<\/li>\n\n\n\n<li><strong>NDC and administration documentation:<\/strong> Linking the NDC to the administration record cuts transcription errors between the chart and the claim form. It also shows at a glance which of the two codes the claim needs.<\/li>\n\n\n\n<li><strong>Prior authorization management:<\/strong> Track PA numbers, approved products, and expiration dates against the appointment calendar. That stops the common case of dosing after the authorization window has closed.<\/li>\n\n\n\n<li><strong>Denial management:<\/strong> When a J-code claim is denied, staff need the reason fast. That could be a product mismatch, a missing NDC, an expired PA, or an unsupported diagnosis. Structured <a href=\"https:\/\/pabau.com\/blog\/practice-management-software\/\">practice management workflows<\/a> keep denial follow-up on a consistent timeline.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Practices administering specialty drugs also benefit from digital records that stay audit-ready. The OIG reviews high-cost J-code billing patterns, so a system-supported workflow is the fastest route through a review.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Connecting your <a href=\"https:\/\/pabau.com\/features\/patient-intake-software\/\">digital intake and consent forms<\/a> to the clinical record keeps every touchpoint traceable. The trail runs from consent through administration to claim submission, which is exactly what an auditor asks to see.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0800\/customizable-consent-and-intake-forms.webp\" alt=\"Customizable consent and intake forms\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&rsquo;s digital intake and consent forms attach to the client record, so an audit can trace consent through to the claim.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Stop billing errors before they become denials                <\/h3>\n\n                <p class=\"description\">\n                    Pabau&rsquo;s claims management tools help practices track J-code crosswalks, NDC requirements, and prior authorization status. Complex buy-and-bill claims clear on the first submission.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau claims management dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0800 is gone, and it did not leave one successor behind. Any practice that still sees it on a claim form, a superbill, or a charge capture template has to replace it. Two entries take its place: J0801 for Acthar Gel and J0802 for Cortrophin Gel.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read the descriptors literally and the choice is simple. J0801 names Acthar Gel, and J0802 names ANI, the maker of Cortrophin Gel. Neither code has anything to do with animal sourcing, since both gels are porcine-derived.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Corticotropin billing is high-stakes work. Acquisition costs are large, PA rules are strict, and the OIG treats high-cost buy-and-bill drugs as a compliance priority. The practices that avoid denials keep the code, the NDC, and the authorization in one place. <a href=\"https:\/\/pabau.com\/book-demo\/\">Book a demo<\/a> to see how Pabau handles the full billing cycle for complex injection claims.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing another high-cost Part B product?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-p9021\/\">P9021<\/a> covers blood product units under the same Part B reporting rules.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Administering a drug through equipment?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-k0455\/\">K0455<\/a> covers infusion pump billing, which is where the KD modifier applies.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need a broader framework for procedure code accuracy?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/bupa-procedure-codes-fee-schedule\/\">Bupa fee schedule guide<\/a> shows how fee schedules and code selection affect reimbursement.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Want to cut administrative load across billing workflows?<\/strong> <a href=\"https:\/\/pabau.com\/blog\/what-is-practice-management-software\/\">Practice management software<\/a> explains how one platform connects documentation, coding, and claim submission.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1786700000000\"><h3 class=\"schema-faq-question\">What is HCPCS code J0800?<\/h3> <p class=\"schema-faq-answer\">HCPCS code J0800 was a Level II J-code that described \u00ab\u00a0injection, corticotropin, up to 40 units.\u00a0\u00bb It was used to bill repository corticotropin (ACTH) injections under the Medicare Part B buy-and-bill model. CMS deleted it on September 30, 2023 and replaced it with two product-specific codes, J0801 and J0802.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000001\"><h3 class=\"schema-faq-question\">Has J0800 been deleted, and what is the replacement code?<\/h3> <p class=\"schema-faq-answer\">Yes. J0800 was deleted effective September 30, 2023, and there are two replacements rather than one. J0801 covers \u00ab\u00a0injection, corticotropin (acthar gel), up to 40 units\u00a0\u00bb and J0802 covers \u00ab\u00a0injection, corticotropin (ani), up to 40 units.\u00a0\u00bb Both took effect on October 1, 2023.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000002\"><h3 class=\"schema-faq-question\">Which code do I use for Acthar Gel?<\/h3> <p class=\"schema-faq-answer\">Acthar Gel claims go under J0801. Payer billing guidance states that J0801 applies to H.P. Acthar Gel only and that J0802 applies to Purified Cortrophin Gel only. Billing Acthar Gel under J0802 is a product mismatch, and payers deny it even when the diagnosis and units are correct.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000003\"><h3 class=\"schema-faq-question\">What does the \u00ab\u00a0(ani)\u00a0\u00bb in J0802 mean?<\/h3> <p class=\"schema-faq-answer\">It stands for ANI Pharmaceuticals, the manufacturer of Purified Cortrophin Gel. It does not mean animal-derived. Both Acthar Gel and Cortrophin Gel are porcine-derived ACTH gels, so drug source is not what separates the two codes. The brand of product in the vial is.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000004\"><h3 class=\"schema-faq-question\">How many units are billed with J0801 or J0802?<\/h3> <p class=\"schema-faq-answer\">One billing unit represents up to 40 USP units of corticotropin, the same convention J0800 used. Divide the administered dose by 40 and round up, so an 80-unit dose is reported as 2 units. Report the NDC quantity separately, in the vial&rsquo;s own unit of measure.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000005\"><h3 class=\"schema-faq-question\">Do J0801 and J0802 require prior authorization?<\/h3> <p class=\"schema-faq-answer\">Prior authorization is required by most payers for both products, including virtually all Medicare Advantage and commercial plans. Traditional Medicare fee-for-service may not require PA in every case, but LCD documentation standards still apply. Authorizations are product-specific, so confirm the approval names the gel you plan to administer.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000006\"><h3 class=\"schema-faq-question\">What ICD-10 codes support a J0801 or J0802 claim?<\/h3> <p class=\"schema-faq-answer\">Shared supporting codes include G35 (multiple sclerosis), N04.9 (nephrotic syndrome), M05.79 (rheumatoid arthritis), M32.9 (systemic lupus erythematosus), and D86.9 (sarcoidosis). G40.821 and G40.822 for infantile spasms sit on the Acthar Gel label, so they support J0801. M10.9 for acute gouty arthritis sits on the Cortrophin Gel label, so it supports J0802.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786700000007\"><h3 class=\"schema-faq-question\">What modifiers apply to J0801 and J0802 claims?<\/h3> <p class=\"schema-faq-answer\">Modifier GA applies when an Advance Beneficiary Notice is on file, and GY is used when billing a non-covered indication for denial documentation. JW and JZ report drug wastage, but they apply to single-dose containers only. Both gels ship in multiple-dose 5 mL vials, so check the vial before appending either one.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>HCPCS code J0800 carried the official description \u00ab\u00a0injection, corticotropin, up to 40 units.\u00a0\u00bb It was the Level II J-code used to bill corticotropin (adrenocorticotropic hormone, or ACTH) given by injection in a physician office or outpatient setting. CMS deleted it effective September 30, 2023. The replacement is not a single code. On October 1, 2023, [&hellip;]<\/p>\n","protected":false},"author":82,"featured_media":180113,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"79","_yoast_wpseo_content_score":"30","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1433,1548],"tags":[1582,2953,2959,2956,1826],"class_list":["post-180114","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-billing-codes","category-hcpcs","tag-hcpcs","tag-j-code-billing","tag-medicare-part-b-drugs","tag-ndc-reporting","tag-prior-authorization"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCPCS code J0800: Deleted, bill J0801 or J0802<\/title>\n<meta name=\"description\" content=\"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCPCS code J0800: Deleted, bill J0801 or J0802\" \/>\n<meta property=\"og:description\" content=\"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-14T08:44:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-14T11:17:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0800.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Maja Popovska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maja Popovska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"15 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/\"},\"author\":{\"name\":\"Maja Popovska\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/b00aec1dd379f0ddcf6137d78e2a21db\"},\"headline\":\"HCPCS code J0800: Corticotropin injection billing guide\",\"datePublished\":\"2026-08-14T08:44:10+00:00\",\"dateModified\":\"2026-08-14T11:17:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/\"},\"wordCount\":3713,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0800.webp\",\"keywords\":[\"Hcpcs\",\"J Code Billing\",\"Medicare Part B Drugs\",\"Ndc Reporting\",\"Prior authorization\"],\"articleSection\":[\"Billing Codes\",\"HCPCS\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/\",\"name\":\"HCPCS code J0800: Deleted, bill J0801 or J0802\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0800.webp\",\"datePublished\":\"2026-08-14T08:44:10+00:00\",\"dateModified\":\"2026-08-14T11:17:26+00:00\",\"description\":\"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000000\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000001\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000002\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000003\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000004\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000005\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000006\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000007\"}],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0800.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0800.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/b00aec1dd379f0ddcf6137d78e2a21db\",\"name\":\"Maja Popovska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Maja-Popovska_WP-1-96x96.jpeg\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Maja-Popovska_WP-1-96x96.jpeg\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Maja-Popovska_WP-1-96x96.jpeg\",\"caption\":\"Maja Popovska\"},\"description\":\"Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/blog\\\/author\\\/maja-popovska\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000000\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000000\",\"name\":\"What is HCPCS code J0800?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"HCPCS code J0800 was a Level II J-code that described \\\"injection, corticotropin, up to 40 units.\\\" It was used to bill repository corticotropin (ACTH) injections under the Medicare Part B buy-and-bill model. CMS deleted it on September 30, 2023 and replaced it with two product-specific codes, J0801 and J0802.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000001\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000001\",\"name\":\"Has J0800 been deleted, and what is the replacement code?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. J0800 was deleted effective September 30, 2023, and there are two replacements rather than one. J0801 covers \\\"injection, corticotropin (acthar gel), up to 40 units\\\" and J0802 covers \\\"injection, corticotropin (ani), up to 40 units.\\\" Both took effect on October 1, 2023.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000002\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000002\",\"name\":\"Which code do I use for Acthar Gel?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Acthar Gel claims go under J0801. Payer billing guidance states that J0801 applies to H.P. Acthar Gel only and that J0802 applies to Purified Cortrophin Gel only. Billing Acthar Gel under J0802 is a product mismatch, and payers deny it even when the diagnosis and units are correct.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000003\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000003\",\"name\":\"What does the \\\"(ani)\\\" in J0802 mean?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It stands for ANI Pharmaceuticals, the manufacturer of Purified Cortrophin Gel. It does not mean animal-derived. Both Acthar Gel and Cortrophin Gel are porcine-derived ACTH gels, so drug source is not what separates the two codes. The brand of product in the vial is.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000004\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000004\",\"name\":\"How many units are billed with J0801 or J0802?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"One billing unit represents up to 40 USP units of corticotropin, the same convention J0800 used. Divide the administered dose by 40 and round up, so an 80-unit dose is reported as 2 units. Report the NDC quantity separately, in the vial's own unit of measure.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000005\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000005\",\"name\":\"Do J0801 and J0802 require prior authorization?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Prior authorization is required by most payers for both products, including virtually all Medicare Advantage and commercial plans. Traditional Medicare fee-for-service may not require PA in every case, but LCD documentation standards still apply. Authorizations are product-specific, so confirm the approval names the gel you plan to administer.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000006\",\"position\":7,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000006\",\"name\":\"What ICD-10 codes support a J0801 or J0802 claim?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Shared supporting codes include G35 (multiple sclerosis), N04.9 (nephrotic syndrome), M05.79 (rheumatoid arthritis), M32.9 (systemic lupus erythematosus), and D86.9 (sarcoidosis). G40.821 and G40.822 for infantile spasms sit on the Acthar Gel label, so they support J0801. M10.9 for acute gouty arthritis sits on the Cortrophin Gel label, so it supports J0802.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000007\",\"position\":8,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0800\\\/#faq-question-1786700000007\",\"name\":\"What modifiers apply to J0801 and J0802 claims?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Modifier GA applies when an Advance Beneficiary Notice is on file, and GY is used when billing a non-covered indication for denial documentation. JW and JZ report drug wastage, but they apply to single-dose containers only. Both gels ship in multiple-dose 5 mL vials, so check the vial before appending either one.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCPCS code J0800: Deleted, bill J0801 or J0802","description":"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/","og_locale":"fr_FR","og_type":"article","og_title":"HCPCS code J0800: Deleted, bill J0801 or J0802","og_description":"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.","og_url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-08-14T08:44:10+00:00","article_modified_time":"2026-08-14T11:17:26+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0800.webp","type":"image\/webp"}],"author":"Maja Popovska","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"\u00c9crit par":"Maja Popovska","Dur\u00e9e de lecture estim\u00e9e":"15 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/"},"author":{"name":"Maja Popovska","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/b00aec1dd379f0ddcf6137d78e2a21db"},"headline":"HCPCS code J0800: Corticotropin injection billing guide","datePublished":"2026-08-14T08:44:10+00:00","dateModified":"2026-08-14T11:17:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/"},"wordCount":3713,"publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"image":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0800.webp","keywords":["Hcpcs","J Code Billing","Medicare Part B Drugs","Ndc Reporting","Prior authorization"],"articleSection":["Billing Codes","HCPCS"],"inLanguage":"fr-FR"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/","url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/","name":"HCPCS code J0800: Deleted, bill J0801 or J0802","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0800.webp","datePublished":"2026-08-14T08:44:10+00:00","dateModified":"2026-08-14T11:17:26+00:00","description":"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.","mainEntity":[{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000000"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000001"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000002"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000003"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000004"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000005"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000006"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000007"}],"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0800.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0800.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/fr\/#website","url":"https:\/\/pabau.com\/fr\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/pabau.com\/fr\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/b00aec1dd379f0ddcf6137d78e2a21db","name":"Maja Popovska","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-Maja-Popovska_WP-1-96x96.jpeg","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-Maja-Popovska_WP-1-96x96.jpeg","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-Maja-Popovska_WP-1-96x96.jpeg","caption":"Maja Popovska"},"description":"Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.","url":"https:\/\/pabau.com\/fr\/blog\/author\/maja-popovska\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000000","position":1,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000000","name":"What is HCPCS code J0800?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"HCPCS code J0800 was a Level II J-code that described \"injection, corticotropin, up to 40 units.\" It was used to bill repository corticotropin (ACTH) injections under the Medicare Part B buy-and-bill model. CMS deleted it on September 30, 2023 and replaced it with two product-specific codes, J0801 and J0802.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000001","position":2,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000001","name":"Has J0800 been deleted, and what is the replacement code?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes. J0800 was deleted effective September 30, 2023, and there are two replacements rather than one. J0801 covers \"injection, corticotropin (acthar gel), up to 40 units\" and J0802 covers \"injection, corticotropin (ani), up to 40 units.\" Both took effect on October 1, 2023.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000002","position":3,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000002","name":"Which code do I use for Acthar Gel?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Acthar Gel claims go under J0801. Payer billing guidance states that J0801 applies to H.P. Acthar Gel only and that J0802 applies to Purified Cortrophin Gel only. Billing Acthar Gel under J0802 is a product mismatch, and payers deny it even when the diagnosis and units are correct.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000003","position":4,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000003","name":"What does the \"(ani)\" in J0802 mean?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"It stands for ANI Pharmaceuticals, the manufacturer of Purified Cortrophin Gel. It does not mean animal-derived. Both Acthar Gel and Cortrophin Gel are porcine-derived ACTH gels, so drug source is not what separates the two codes. The brand of product in the vial is.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000004","position":5,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000004","name":"How many units are billed with J0801 or J0802?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"One billing unit represents up to 40 USP units of corticotropin, the same convention J0800 used. Divide the administered dose by 40 and round up, so an 80-unit dose is reported as 2 units. Report the NDC quantity separately, in the vial's own unit of measure.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000005","position":6,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000005","name":"Do J0801 and J0802 require prior authorization?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Prior authorization is required by most payers for both products, including virtually all Medicare Advantage and commercial plans. Traditional Medicare fee-for-service may not require PA in every case, but LCD documentation standards still apply. Authorizations are product-specific, so confirm the approval names the gel you plan to administer.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000006","position":7,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000006","name":"What ICD-10 codes support a J0801 or J0802 claim?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Shared supporting codes include G35 (multiple sclerosis), N04.9 (nephrotic syndrome), M05.79 (rheumatoid arthritis), M32.9 (systemic lupus erythematosus), and D86.9 (sarcoidosis). G40.821 and G40.822 for infantile spasms sit on the Acthar Gel label, so they support J0801. M10.9 for acute gouty arthritis sits on the Cortrophin Gel label, so it supports J0802.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000007","position":8,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0800\/#faq-question-1786700000007","name":"What modifiers apply to J0801 and J0802 claims?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Modifier GA applies when an Advance Beneficiary Notice is on file, and GY is used when billing a non-covered indication for denial documentation. JW and JZ report drug wastage, but they apply to single-dose containers only. Both gels ship in multiple-dose 5 mL vials, so check the vial before appending either one.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"}]}},"yoast":{"focus_keyword":"HCPCS code J0800","seo_title":"HCPCS code J0800: Deleted, bill J0801 or J0802","meta_description":"J0800 was deleted on September 30, 2023. Bill J0801 for Acthar Gel and J0802 for Cortrophin Gel, same 40-unit convention.","content_score":"30","is_cornerstone":"","related_keyphrases":[{"keyword":"J0800 Medicare reimbursement","score":61},{"keyword":"J0800 deleted code","score":61},{"keyword":"buy-and-bill corticotropin","score":72},{"keyword":"HCPCS code lookup","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/180114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/comments?post=180114"}],"version-history":[{"count":4,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/180114\/revisions"}],"predecessor-version":[{"id":180453,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/180114\/revisions\/180453"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media\/180113"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media?parent=180114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/categories?post=180114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/tags?post=180114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}